HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Arthrotec

HCID 3032
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
15307-79-6
Standard SMILES
O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl
InChIKey
DCOPUUMXTXDBNB-UHFFFAOYSA-M
Molecular formula
C14H10Cl2NO2-
Average molar mass
295.1 g/mol
Monoisotopic mass
294.0088589

Overview

Diclofenac(1-) is the conjugate base of diclofenac. It is a conjugate base of a diclofenac.

Names & identifiers

Preferred name
Arthrotec
IUPAC
2-[2-(2,6-dichloroanilino)phenyl]acetate
English name
Diclofenac sodium
Molecular formula
C14H10Cl2NNaO2
Molecular weight
318.13

Names & synonyms

ArthrotecRefChem:916257239810-53-8diclofenac(1-)2-[2-(2,6-dichloroanilino)phenyl]acetate{2-[(2,6-dichlorophenyl)amino]phenyl}acetateOrthophen86522-08-9CHEBI:48311DTXSID201189538BDBM50174201NSC755403
Show more names
DICLOFENAC SODIUM SALTVOLTARENSolarazetsudohminDiclofenac SodiuAceclofenac EP IMpurity ASODIUM 2-(2,6-DICHLOROANILINO)PHENYLACETATEsodium 2-[2-(2,6-dichloroanilino)phenyl]acetateN-(2,6-Dichlorophenyl)-o-aminophenylacetic acid sodium saltNaclof
STK177318AKOS000305881NSC-755403[2-(2,6-dichloroanilino)phenyl]acetateNCGC00021336-03NCGC00021336-04NCGC00021336-05NCGC00021336-09

Database identifiers

CAS
15307-79-6、86522-08-9
PubChem CID
3032
DTXSID
DTXSID201189538
ChEBI

Properties

Computed structural properties

XLogP
5
Topological polar surface area
52.2 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
3
Heavy atoms
19
Formal charge
-1
Complexity
298

Physicochemical properties

Melting point
288 · 288-290°C
Density
0.781 g/cm3 · 0.781 g/cm3
storage temp.
room temp
solubility
2 O: · H2O: 50 mg/mL
pka
4 · 4(at 25℃)
form
White solid
color
White to Almost white
biological source
synthetic
Water Solubility
50 mg/ml · Soluble in water to 50mg/ml.
Merck
14 · 14,3081
BCS Class
2 · 2
Stability
Stable.
Major Application
forensics and toxicologypharmaceutical (small molecule)
InChI
InChI=1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1
InChIKey
KPHWPUGNDIVLNH-UHFFFAOYSA-M
SMILES

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
3
rtecs
AG6330000
ridadr
UN 2811 6.1/PG 3
hs_code
29224999
Toxicity
LD50 in mice, rats (mg/kg): ~390, 150 orally (Krupp)
risk_code
25-36/37/38-63
Signal word
Danger
Symbol(GHS)
GHS06,GHS08,GHS09
hazard_code
T,Xi
safety_code
22-36/37-45-36-26-60-20
hazard_class
6.1(b)
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
III
Hazard statements
H301-H361d-H372-H411
Limited Quantities
5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)
REACH Registrations
Active
Hazard Classifications
Acute Tox. 3 OralAquatic Chronic 2Repr. 2STOT RE 1
Precautionary statements
P201-P202-P260-P264-P273-P301+P310

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 1 item

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Applications · 5 items

UsesDiclofenac is a phenylacetic acid derivative belonging to the class of the non-selective non-steroidal anti-inflammatory drugs (NSAIDs). It exhibits analgesic, antipyretic and anti-inflammatory activity. Due to its poor solubility, the parenteral formulation of diclofenac sodium (Voltarol ampoules) currently available in Europe contains the solvents propylene glycol and benzyl alcohol that allows intramuscular and intravenous administration. Diclofenac sodium has long been used to treat acute pain and inflammation, and is effective in various acute forms of pain.

DescriptionDiclofenac is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 0.9-2.7 and 1.5-20 μM, for human COX-1 and COX-2, respectively). It is also an active metabolite of diclofenac methyl ester and diclofenac amide . Diclofenac inhibits release of arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) induced by A23187 in isolated rat peritoneal neutrophils and macrophages (IC50s = 60 and 10 μM, respectively). Transdermal administration of diclofenac inhibits carrageenan-induced paw edema in rats. Formulations containing diclofenac have been used in the treatment of pain associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

HistoryDiclofenac sodium is a classic nonsteroidal anti-inflammatory drug (NSAID), known for its potent antipyretic, analgesic, and anti-inflammatory effects, and is marketed under brand names such as Voltaren. Its discovery and widespread use have had a profound impact on the treatment of pain and inflammation.Discovery and Patent (1965): Diclofenac sodium was synthesized by a team of researchers Rudolf Pfister and Alfred Sallmann at the Swiss pharmaceutical company Ciba-Geigy AG (now part of Novartis) while searching for a highly active and well-tolerated NSAID. The compound was patented in 1965.First Market Launch (1973): After extensive preclinical and clinical trials, diclofenac sodium was first marketed globally in 1973 under the brand name Voltaren. Its design philosophy is based on clear principles and aims to be an effective cyclooxygenase (COX) inhibitor.

Related reactions

20 records
New reaction record
HRID 93667 reaction equation
HRID 93667As reactant
HRID 96787 reaction equation
HRID 96787As reactant
HRID 136958 reaction equation
HRID 136958As reactant
HRID 143311 reaction equation
HRID 143311As reactant
HRID 150772 reaction equation
HRID 150772As reactant
HRID 155048 reaction equation
HRID 155048As reactant
HRID 188080 reaction equation
HRID 188080As reactant
HRID 207327 reaction equation
HRID 207327As reactant
PreviousPage 1 of 3

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
CHEBI:48311
Nikkaji
J1.539.129D
C1(=CC=CC=C1CC([O-])=O)NC1=C(Cl)C=CC=C1Cl.[Na+]
CAS DataBase Reference
15307 · 15307-79-6(CAS DataBase Reference)
NCI Dictionary of Cancer Terms
diclofenac sodium; Voltaren
FDA UNII
126297 Q · QTG126297Q
NCI Drug Dictionary
diclofenac sodium
UNSPSC Code
41116107 · 41116107
NACRES
77 · NA.77
Protein binding
99.7 % · 99.7%
Excreted unchanged in urine
1 % · <1%
Volume of distribution
0.12 · 0.12-0.17(L/kg)
Biological half-life
1 · 1-2 / Unchanged
Symbol(GHS)
6 · GHS06,GHS08,GHS09
Signal word
Danger
Hazard statements
301 · H301-H361d-H372-H411
Precautionary statements
201 · P201-P202-P260-P264-P273-P301+P310
Hazard Codes
T,Xi
Risk Statements
25 · 25-36/37/38-63
Safety Statements
22 · 22-36/37-45-36-26-60-20
RIDADR
2811 · UN 2811 6.1/PG 3
WGK Germany
3 · 3
RTECS
6330000 · AG6330000
HazardClass
6.1 · 6.1(b)
PackingGroup
III
HS Code
29224999 · 29224999
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralAquatic · Acute Tox. 3 OralAquatic Chronic 2Repr. 2STOT RE 1
Toxicity
50 in · LD50 in mice, rats (mg/kg): ~390, 150 orally (Krupp)
REACH Registrations
Active
Limited Quantities
5 kg · 5.0 kg (11 lbs) (solid)
Excepted Quantities
Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)

UsesDiclofenac sodium is a nonsteroidal anti-inflammatory compound and cyclooxygenase (COX) inhibitor. Oxidation of diclofenac sodium produces the metabolite 4'-hydroxy diclofenac) which demonstrates specific inhibition of Cox-2. Inhibition of Cox by diclofenac and 4'-hydroxy diclofenac suppresses prostaglandin E2 synthesis, producing anti-inflammatory and analgesic effects. Diclofenac is also shown to stabilize the native tetrameric conformation of transthyretin (TTR) fibrils, preventing the formation of insoluble amyloidogenic TTR deposits. Diclofenac Sodium is a substrate of CYP2C9. It is also used as an inhibitor of Cox-1 and Cox-2.

General DescriptionPharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Diclofenac is a derivative of benzeneacetic acid. It is categorized under the class of non-steroidal anti-inflammatory drugs (NSAIDs). It shows inflammatory, analgesic and antipyretic activities.

Upstream & downstream products

Upstream raw materials

EthanolChloroacetyl chloride2,6-Dichlorophenol2-Chlorobenzoic acidAniline2,5-Dichloroaniline2-Chlorotoluene2,6-DichloroanilineSodium hydroxideAluminum chloride

Downstream products

1-(2,6-Dichlorophenyl)-2-hydroindoleDiclofenac methyl esterOxindole

Additional notes

DefinitionChEBI: Diclofenac sodium is the sodium salt of diclofenac. It contains a diclofenac(1-).